A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for ...

chronic obstructive pulmonary disease (COPD), and ... How a New Gut Microbe Drives the Gut-Lung Axis Dec. 19, 2024 — A team has discovered a new communication pathway between the gut and lung.

Image credit: Visual Vic/Getty Images. Researchers estimate the number of people globally living with chronic obstructive pulmonary disease (COPD) will hit 600 million by 2050. There are certain ...

Millions are affected by lung conditions, often unaware of risks. Asthma + Lung UK's Andy Whittamore shares tips for ...

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...

Objective: To investigate the prevalence of daytime hypercapnia in patients with OSAS; the association of daytime hypercapnia and obesity, obstructive airflow limitation, restrictive lung ...

Among patients with COPD, those receiving 6-week nicotinamide riboside, “a B3-like vitamin,” had significantly decreased lung ...

will be honored for her “groundbreaking” work on preventing and treating graft-versus-host disease during the 2025 Tandem Transplantation & Cellular Therapy Meetings of the American Society ...

When added to chemotherapy, researchers found no significant difference in overall or progression-free survival between PD-1 ...

High doses for long periods of time (>6 months). Elderly patients. The presence of psychiatric disease. Risk population (history of addictive behaviour). Tolerance. The efficacy and safety of ...

Vascular dementia is the second most common form of dementia after Alzheimer's disease. It is caused by reduced blood flow to the brain, which starves brain cells of the oxygen and nutrients they need ...